MedPath

To assess the efficacy of probiotic combination as an adjunct to scaling and root planing in reducing gingival inflammation and pocket depth in chronic moderate periodontitis patients.

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: A488- Other specified bacterial diseasesHealth Condition 3: A488- Other specified bacterial diseases
Registration Number
CTRI/2019/10/021630
Lead Sponsor
Aristo pharma pvt ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

no recent antibiotic therapy within 4 weeks

-non smokers

-subjects with gingivitis defined as mean gingival index >1.3

-patient with 3-4 mm attachment loss and 5-8 mm pocket in atleast 30% sites examined

Exclusion Criteria

- patients using any other comercially available mouthrinse,probiotic products,or any other oral hygiene aids other than routine teeth brushing

-subjects taking medications that could interfere with gingival tissue response.

-subjects currently undergoing orthodontic treatment

-systemic disease or conditions which may affect the response of gingival tissies or the ability to perform adequate plaque contro

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected to get an improved periodontal health when Darolac probiotic mouthrinse is used as an adjunct to scaling and root planning compared to SRP alone.Timepoint: 5 minutes
Secondary Outcome Measures
NameTimeMethod
It is expected to get an improved periodontal health when Darolac probiotic mouthrinse is used as an adjunct to scaling and root planning compared to SRP alone.Timepoint: 5 minutes
© Copyright 2025. All Rights Reserved by MedPath